| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |